Cookie confirmation

PUBLICATIONS / NUMBER 131

Stay on top of all key Pharmacovigilance Regulatory requirements

We do the search and bring you the regulatory information you need to achieve compliancein your Pharmacovigilance operations.

Feb 2017

Feb 2017

SAFETY OBSERVER N131

17 PAGES

  • ICH starts consultation on GCP Renovation

  • US issue final revisions to the rules for Clinical Trials oversight

  • FDA issues final guidance on Assessment of Abuse Potential

  • ANSM advises against the use of Selexipag (Uptravi) in new patients

Receive release updates for free
Register now

Back issues